Macquarie bullish on Suven Pharma, Divi’s Labs, Bluejet and Syngene

February 20, 2025

Macquarie said that the sector is currently at a turning point, driven by increased pharmaceutical outsourcing due to drug pricing pressures and geopolitical factors, prompting a global restructuring of the pharmaceutical supply chain.

More To Explore

High margin requirements will discourage undue speculation in electricity futures: Sebi Chief Pandey

A high initial-margin requirement will discourage “undue speculation” in the newly-launched electricity futures segment, Sebi chief Tuhin Kanta Pandey said on Friday.

July 18, 2025

IndusInd Bank to consider raising funds via long-term bonds

IndusInd Bank is set to discuss raising funds through long-term bonds at its upcoming board meeting on July 23. This consideration follows a $230 million

July 18, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003